Prestige Consumer Healthcare (PBH) Non-Current Debt (2011 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Non-Current Debt came in at $1.0 billion in Q4 2025, up 4.19% year-on-year from $992.0 million in Q4 2024, and up 4.07% quarter-over-quarter from $993.1 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Non-Current Debt (2011 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Non-Current Debt history runs 15 years deep, the most recent figure standing at $1.0 billion for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 4.19% year-over-year to $1.0 billion in Q4 2025; TTM through Dec 2025 was $1.0 billion, a 4.19% increase from a year earlier, with the FY2025 full-year figure at $992.4 million, down 11.85% from the prior year.
  • Non-Current Debt climbed to $1.0 billion in Q4 2025 per PBH's latest filing, from $993.1 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.6 billion in Q3 2021 and bottomed at $992.0 million in Q4 2024.
  • The 5-year median for Non-Current Debt is $1.3 billion (2023), against an average of $1.3 billion.
  • Across the five-year window, Non-Current Debt declined 17.29% in 2024 and increased 4.19% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $1.5 billion in 2021, then slipped by 6.94% to $1.4 billion in 2022, then retreated by 15.78% to $1.2 billion in 2023, then retreated by 17.29% to $992.0 million in 2024, then increased by 4.19% to $1.0 billion in 2025.
  • Per Business Quant, the three latest PBH Non-Current Debt figures stand at $1.0 billion (Q4 2025), $993.1 million (Q3 2025), and $992.7 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 1.03 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.03 Bn
Sep 30, 2025 993.15 Mn
Jun 30, 2025 992.75 Mn
Mar 31, 2025 992.36 Mn
Dec 31, 2024 991.97 Mn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 1.09 Bn
Mar 31, 2024 1.13 Bn
Dec 31, 2023 1.20 Bn
Sep 30, 2023 1.26 Bn
Jun 30, 2023 1.32 Bn
Mar 31, 2023 1.35 Bn
Dec 31, 2022 1.42 Bn
Sep 30, 2022 1.44 Bn
Jun 30, 2022 1.47 Bn
Mar 31, 2022 1.48 Bn
Dec 31, 2021 1.53 Bn
Sep 30, 2021 1.59 Bn
Jun 30, 2021 1.55 Bn
Mar 31, 2021 1.48 Bn